McKinsey: US firms' AI investments in '16 made up 66% of global total, with China next at 17%; tech firms spent $20B-$30B on AI: 90% on R&D, 10% on acquisitions
- Tech giants including Baidu and Google spent between $20B to $30B on AI in 2016, with 90% of this spent on R&D and deployment, and 10% on AI acquisitions.
Context & Ripple Effects
McKinsey's 2016 baseline put US firms at 66% of global AI investment against China's 17%, with giants like Google and Baidu directing $20B–$30B into AI but splitting it 90/10 between internal R&D and acquisitions. That split matters because the small M&A slice still seeded a durable buying pipeline — GlobalData later counted 60 AI companies bought by Apple, Google, Microsoft, and Facebook between 2016 and 2020.
The startup-funding side moved faster than the corporate spend: within a year, CB Insights recorded AI startup investment jumping 141% to $15.2B, with Chinese companies taking 48% of that funding versus 38% for US ones — an early signal that the McKinsey gap would not close linearly.
First-order effects
- Google and Baidu are committing nearly all their AI budgets to building capability in-house rather than buying it, leaving only about a tenth of the $20B–$30B for acquisitions and squeezing the exit market for AI startups relative to internal hiring and research.
Second-order effects
- The 10% acquisition allocation still translates into a steady consolidation channel — the four largest US buyers alone absorbed 60 AI companies by 2020 — while China's share of startup funding overtaking America's forces US investors to compete for deal flow at higher valuations.
Third-order effects
- The 66%-vs-17% gap proved temporary rather than structural: by mid-2023 Preqin measured US AI investment at $26.6B against China's $4B, and reporting through late 2025 indicates Chinese state and corporate capital pivoted toward EVs and robotics — meaning AI leadership oscillates with where each government directs industrial policy, not with any single year's totals.
The trend: Global AI investment is a moving target where US corporate R&D dominance alternates with Chinese state-directed funding surges, making single-year shares unreliable predictors of the competitive balance.